background image

Paid Clinical Trials Indiana

Discover 1,139 paid clinical trials in Indiana. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

An Efficacy and Safety Evaluation of HORIZANT in Adolescents With Moderate-to-Severe Primary RLS

Recruiting

Sponsor:

XenoPort, Inc.

Location:

Indianapolis, Toledo, Saint Louis, Nashvilleshow 8 more

Code:

NCT02560766

Conditions

RLS

Eligibility Criteria

Sex: All

Age: 13 - 17

Healthy Volunteers: Not accepted

Interventions

HORIZANT 300 mg

HORIZANT 600 mg

Placebo

Rare and Atypical Diabetes Network

Recruiting

Sponsor:

University of South Florida

Location:

Indianapolis, Chicago, Ann Arbor, Saint Louisshow 9 more

Code:

NCT05544266

Conditions

Diabetes Mellitus

Diabetes Mellitus Progression

Glucose Intolerance

Glucose Metabolism Disorders

Metabolic Disease

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

First in Human Study of TORL-2-307-ADC in Participants With Advanced Cancer

Recruiting
PHASE1

Sponsor:

TORL Biotherapeutics, LLC

Location:

Fort Wayne, Saint Louis, San Antonio, Fullertonshow 2 more

Code:

NCT05156866

Conditions

Advanced Solid Tumor

Gastric Cancer

Pancreas Cancer

Gastroesophageal Junction Adenocarcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

TORL-2-307-ADC

A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

Recruiting

Sponsor:

Target PharmaSolutions, Inc.

Location:

Indianapolis, Louisville, Chicago, Columbusshow 51 more

Code:

NCT03661866

Conditions

Atopic Dermatitis

Alopecia Areata

Hidradenitis Suppurativa

Vitiligo

Psoriasis

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Recruiting
PHASE3

Sponsor:

AstraZeneca

Location:

Blue Ash, Beavercreek, Valparaiso, Chicagoshow 195 more

Code:

NCT06283966

Conditions

COPD (Chronic Obstructive Pulmonary Disease)

Eligibility Criteria

Sex: All

Age: 40 - 70+

Healthy Volunteers: Not accepted

Interventions

BGF MDI 320/14.4/9.6 μg

GFF MDI 14.4/9.6 μg

A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression

Recruiting
PHASE1
PHASE2

Sponsor:

Amgen

Location:

Indianapolis, Detroit, Toronto, Ottawashow 8 more

Code:

NCT05325866

Conditions

Solid Tumors

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Bemarituzumab

Satisfaction With eMotion in a Diverse Group of Women

Recruiting

Sponsor:

Indiana University

Location:

Indianapolis

Code:

NCT06404866

Conditions

Cardiac Events

Emotions

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

eMotion

A Study to Investigate the Effect on Lung Function of BDA Formulated With a New Propellant (HFO) Compared With an Approved Asthma Treatment (BDA With HFA Propellant) in Participants With Asthma

Recruiting
PHASE3

Sponsor:

AstraZeneca

Location:

Cincinnati, Louisville, Valparaiso, Evansvilleshow 64 more

Code:

NCT06502366

Conditions

Asthma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BDA MDI HFO 160/180 μg

BDA MDI HFA 160/180 μg

Placebo MDI HFA

Medtronic Terminate AF Study

Recruiting

Sponsor:

Medtronic Cardiac Surgery

Location:

Indianapolis, Toledo, Grand Rapids, Saint Louisshow 10 more

Code:

NCT03546374

Conditions

Persistent Atrial Fibrillation

Longstanding Persistent Atrial Fibrillation

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Surgical Ablation

Cardioblate and Cryoflex hand held devices

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Recruiting
PHASE3

Sponsor:

Merck Sharp & Dohme LLC

Location:

Fort Wayne, Skokie, Zanesville, Osage Beachshow 13 more

Code:

NCT06393374

Conditions

Triple-Negative Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pembrolizumab

sac-TMT

Capecitabine

Popular cities in Indiana

Indianapolis